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Abstract
Background: Depression is one of the leading causes of disability worldwide. Internet- and computer-based interventions (IBIs)
have been shown to provide effective, scalable forms of treatment. More than 100 controlled trials and a growing number of
meta-analyses published over the past 30 years have demonstrated the efficacy of IBIs in reducing symptoms in the short and
long term. Despite the large body of research, no comprehensive review or meta-analysis has been conducted to date that evaluates
how the effectiveness of IBIs has evolved over time.
Objective: This systematic review and meta-analysis aims to evaluate whether there has been a change in the effectiveness of
IBIs on the treatment of depression over the past 30 years and to identify potential variables moderating the effect size.
Methods: A sensitive search strategy will be executed across the Cochrane Central Register of Controlled Trials (CENTRAL),
MEDLINE, EMBASE, and PsycINFO. Data extraction and evaluation will be conducted by two independent researchers. Risk
of bias will be assessed. A multilevel meta-regression model will be used to analyze the data and estimate effect size.
Results: The search was completed in mid-2019. We expect the results to be submitted for publication in early 2020.
Conclusions: The year 2020 will mark 30 years since the first paper was published on the use of IBIs for the treatment of
depression. Despite the large and rapidly growing body of research in the field, evaluations of effectiveness to date are missing
the temporal dimension. This review will address that gap and provide valuable analysis of how the effectiveness of interventions
has evolved over the past three decades; which participant-, intervention-, and study-related variables moderate changes in
effectiveness; and where research in the field may benefit from increased focus.
Trial Registration: PROSPERO CRD42019136554; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=136554
International Registered Report Identifier (IRRID): PRR1-10.2196/14860
(JMIR Res Protoc 2020;9(3):e14860)  doi: 10.2196/14860
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Depression is one of the leading causes of disability worldwide,
with global prevalence rates estimated at 4.7% [1,2]. Depression
has been identified as a risk factor for many chronic health
conditions [3], is associated with poor quality of life [4], has a
significant burden of fatal and nonfatal disease [5], and a highly
negative economic impact [6].
Cognitive behavioral therapy (CBT) is the most widely practiced
and researched form of psychotherapy for depression, with an
extensive body of research supporting its efficacy in reducing
depressive symptoms [7,8].
Despite the demonstrated efficacy, the World Health
Organization estimates that approximately 34 million people
suffering from major depressive disorder go untreated each year
in Europe and the United States alone, representing a treatment
gap of more than 56% [9]. Barriers to effective care include
difficulty accessing a nearby provider, the prohibitive cost of
treatment, lack of insurance and trained health care providers,
long waiting list times, and the social stigma associated with
mental disorders [10,11].
The development of internet- and computer-based therapy has
provided an effective method of meeting some of these
challenges. Emerging in 1990, the first version of
computer-based CBT (cCBT) was effectively a CBT manual
delivered via a CD-ROM [12]. However, with the development
and widespread adoption of the internet in the 1990s, internet
delivery became the norm [13].
During an internet- or computer-based intervention (IBI),
patients typically log in to a website to read, watch, hear, and
download materials arranged into a series of lessons or modules.
They receive homework assignments and regularly complete
computer-administered questionnaires relevant to their
presenting problems, allowing a therapist or other support person
to monitor their progress and outcomes [14,15].
There are a number of advantages offered by IBIs over
traditional forms of face-to-face therapy [14]. First, in the case
of online interventions, the ability for patients to access IBIs at
anytime and from anywhere with an internet connection
significantly lowers the barrier to access. Second, the anonymity
of IBIs allows patients to circumvent the stigma surrounding
mental disorders, which prevents many from even mentioning
their problems when consulting general practitioners. Finally,
the time savings associated with internet-delivered therapy has
enabled health care providers to increase the delivery of therapy
and reduce wait-list times, making it a highly scalable form of
therapy.
Over the past 30 years, IBIs have been developed and tested for
a range of mental disorders, the most common of which are
anxiety and depression disorders [16]. Interventions have
employed a variety of therapeutic approaches—from CBT [16]
to acceptance and commitment therapy [17], psychodynamic
approaches [18], and interpersonal psychotherapy [19].
Effectiveness of Internet- and Computer-Based
Interventions
The most widely researched type of IBI is internet-delivered
cognitive behavior therapy (iCBT), with more than 100
randomized controlled trials (RCTs) and a growing number of
effectiveness studies [20-22] and meta-analyses [8,23-35]
demonstrating its efficacy. One of the earliest meta-analyses by
Spek et al [23] found a moderate posttreatment effect size across
12 RCTs for participants with depression compared with control
groups. Subsequent reviews have reported similar findings, with
pooled standardized mean differences ranging from Cohen d=.32
[23] to Hedges’ g=0.78 [25] for interventions compared with
placebo, treatment as usual, and wait-list. A particularly
important comparison for IBIs is traditional, face-to-face
therapy. Although there have been few trials to date, a
meta-analysis by Carlbring et al [35] indicated that there was
no significant difference between iCBT and face-to-face
treatments, a finding supported by Webb et al [36]. In addition
to RCTs, a number of effectiveness studies have demonstrated
that iCBT can be effectively delivered in routine clinical
practice, with effects similar to those observed in efficacy trials
[21,22]. One notable (although widely debated) exception to
these findings was the large-scale REEACT (Randomised
Evaluation of the Effectiveness and Acceptability of
Computerised Therapy) trial, which compared two iCBT
interventions (Beating the Blues and MoodGYM) with usual
general practitioner care in a primary care setting in the in which
it was concluded that the benefits of IBIs demonstrated in
efficacy trials may not transfer to clinical settings [37].
Finally, small but significant effect size superiority has been
shown at both 3- to 6- and 9- to 18-month follow-ups indicating
the potential for IBIs to deliver sustained benefits over time
[26].
Despite these positive findings, the growing number of RCTs
and meta-analyses conducted to date only provide a pooled
estimate of effect size at a singular point in time. To the best of
our knowledge, no research has been published that evaluates
how the effectiveness of IBIs has evolved over time. That is to
say, have outcomes improved, deteriorated, or remained the
same? Therefore, the primary aim of the proposed study is to
examine the effect of time on the effectiveness of IBIs in the
treatment of depression, in which the term “effectiveness” will
be used to encompass both efficacy and effectiveness trials [38].
As a result of significant advances in digital technology over
the past 30 years, together with a greater understanding of the
moderators of change in IBIs, we hypothesize that the
effectiveness of IBIs has increased with time.
Factors Influencing the Effectiveness of Internet- and
Computer-Based Interventions
As the field of IBIs has developed over the past 30 years, an
increasing number of studies have looked at the factors
influencing effectiveness. Researchers have identified a broad
range of factors related to (1) participant characteristics, (2)
intervention components, and (3) study design and quality.
Regarding participant characteristics, marital status, education
level, gender, and pretreatment depression severity have all
JMIR Res Protoc 2020 | vol. 9 | iss. 3 | e14860 | p. 2http://www.researchprotocols.org/2020/3/e14860/
(page number not for citation purposes)
Moshe et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
been shown to influence outcomes [39-42]. However, it is
important to note that methodological and power limitations
may affect the reliability of these findings, which may also
account for the considerable variability found across studies
[43,44]. In a small but growing number of trials looking at age,
IBIs have also been shown to be effective in the treatment of
depression for both children and older adults [45,46].
When it comes to intervention components, IBIs vary
considerably in the therapeutic approach adopted, the design of
the platform, the content used, and the mode of delivery. Perhaps
the most significant and consistent finding regarding the impact
of intervention components on effectiveness is the role of human
support or “guidance,” in which a number of RCTs and
meta-analyses have demonstrated that guided interventions lead
to greater effect sizes than unguided interventions
[15,32,33,44,47]. Additional research has also studied the impact
of the amount of guidance received (the dose-response
relationship), the qualification of those providing guidance (eg,
therapist versus administrative personnel), the communication
mode (email, phone, video chat) [15,32,34], and the acceptability
of guided and unguided interventions compared with other
delivery formats [47].
Another important factor influencing the reported effectiveness
of IBIs is study design and quality. Researchers have long been
aware of the substantial heterogeneity between studies in the
field, leading to inconsistent effect sizes. In recent years,
concerns over a number of methodological shortcomings
affecting much of the research have been raised. A meta-analysis
by Richards and Richardson [15], for example, revealed a high
risk of missing data in RCTs as well as possible publication
bias. In an in-depth review of study design and quality, Arnberg
et al [48] reported on the lack of proper quality assessment and
objective outcome measures, the paucity of noninferiority trials,
the relatively small sample sizes in most trials, a focus on
short-term outcomes, the failure to report on deterioration and
adverse events, and the overrepresentation of trials conducted
in a limited number of countries threatening generalizability.
The type of control used in the study has also been shown to
have a significant impact on effectiveness. As Webb et al [36]
pointed out, the majority of iCBT studies have used a wait-list
as their control condition, which a number of researchers have
demonstrated leads to a significantly greater effect size than
care as usual [49-52]. If this is indeed the case, research would
benefit considerably from understanding whether any potential
increase in the effectiveness of IBIs over the past decades is a
result of an improvement in the interventions themselves or
simply a result of changes in study design and quality. In so
doing, we would also reveal how methodological standards in
the field have developed over time, exposing potential
shortcomings that need to be addressed.
Aims and Objectives
Using a meta-regression analysis, this study will examine
whether there has been a change in the effectiveness of IBIs for
the treatment of depression over the past 30 years independent
of study-related moderating variables. It will also describe
relevant developments in the field over time (eg, populations
studied, changes in intervention design, study quality, and
sample size).
Methods
This protocol has been developed in line with the PRISMA
(Preferred Reporting Items for Systematic Review and
Meta-Analysis) protocols statement [53]. The systematic review
and meta-analysis has been registered with the PROSPERO
(International Prospective Register of Systematic Reviews)
database (registration number: CRD42019136554).
Eligibility Criteria
In accordance with the PRISMA checklist recommendations,
this review will use the participants, interventions, comparators,
and outcome(s) process for framing and reporting the review
criteria, and the study design of the included studies will be
reported (Textbox 1).
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Textbox 1. PICOS (participants, interventions, comparators, outcomes, and study design) elements of the study inclusion criteria.
Participants
• Individuals of all age groups and gender with depressive symptoms
Interventions
• Internet- and computer-based psychological interventions (IBI) (eg, IBI with guidance, IBI without guidance)
Comparators
• Wait-list




• Symptom-specific: depression severity
• Intervention-related: acceptability
Study design
• Randomized controlled trials published in peer-reviewed journals
Participants
We will include studies of people of all age groups and genders
with depressive symptoms. No restrictions regarding ethnicity
and cultural background will be applied.
Interventions
Included studies must report on one or more interventions that
are based on psychological interventions. A multitude of
different psychological interventions are available. Following
Kampling et al [54], we differentiate between (1) CBT (eg,
problem solving), (2) psychodynamic psychotherapy (eg,
psychoanalytic therapy), (3) behavior therapy or behavior
modification (eg, exposure therapy), (4) systemic therapy (eg,
family therapy), (5) third-wave CBTs (eg, acceptance and
commitment therapy), (6) humanistic therapies (eg, Rogerian
therapy), (7) integrative therapies (eg, interpersonal therapy)
and other psychological-oriented interventions (eg,
bibliotherapy) [54].
Interventions must be provided via a computer or mobile device
(eg, tablet or mobile phone) in either an offline or online setting,
defined as computerized-, online-, internet-, or Web-based.
Interventions that are delivered solely via mobile apps will be
excluded due to differences in the way they approach diagnosis
and delivery of the intervention compared with IBIs, as well as
significant heterogeneity between the apps themselves (eg, the
use of ecological momentary assessments, duration of tasks or
modules, and use of conversational agents) [14,55]. We will
include both guided and unguided interventions. Guided
interventions will refer to interventions that are primarily based
on self-help material but accompanied by some form of minimal
human guidance related to the therapeutic content. In line with
Karyotaki et al [44], guidance will be considered minimal if it
is provided at low intervals and through electronic means, such
as email, phone, and online messaging (eg, brief email feedback
on weekly homework). We will consider an intervention
unguided if it is self-help with no human guidance or support
relating to the therapeutic content. Studies involving “blended
therapy” (where computerized therapy is combined with
face-to-face therapy) will be excluded because the therapeutic
support here differs substantially from minimal therapeutic
contact provided in guided interventions.
Comparators
We will include all RCTs with an inactive control condition
(eg, treatment as usual, attention control condition, wait-list
control, or no treatment). Studies will be excluded if they
compared the intervention to an active control (eg, face-to-face
therapy or pharmacotherapy). In cases of multiple comparators
or multiple interventions and one comparator in one study, all
comparisons between intervention group(s) and comparator(s)
will be included separately. We will use a three-level
meta-regression model to account for dependencies (see Data
Analysis).
Outcomes
The primary outcome will be effect size in depressive
symptomatology measured by validated self- or clinician-rated
depression scales. Multiple effect sizes (eg, multiple outcomes
or multiple groups) will be included separately. Resulting
dependencies will be accounted for in the three-level
meta-analysis [56].
Intention-to-treat data, if available, will be used for the primary
analysis. Secondary analyses will be reported for per-protocol
data. The per-protocol analysis will be based on the sample of
participants who adequately adhered to the intervention protocol
by completing at least 80% of sessions [57].
As a secondary outcome, we will include acceptability of
treatment, operationalized as the proportion of patients who left
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the study early for any reason during the acute phase of
treatment [58].
Study Design
Parallel RCTs will be included. Published, peer-reviewed,
full-text articles in all languages will be included.
Predictors and Moderators
This study will investigate the following potential moderators
of effect size over time: (1) pretreatment depression severity,
(2) guidance, (3) comorbidities, (4) control group, and (5) study
quality. Time will be operationalized as the year of publication.
Pretreatment depression severity will be operationalized using
the sum score of a validated rating scale. Preference will be
given to the measure reported by the majority of the included
studies. In studies using different outcome measures, the score
will be converted into the most commonly used scale using the
established conversion algorithms [59]. If this approach does
not cover a substantial proportion of the obtained data, scale
scores will be transformed into z scores to create a standardized
common metric for pretreatment depression severity [34,60].
Guidance will be operationalized as being either “guided” or
“unguided” interventions. Guided interventions will be defined
as support related to the therapeutic content provided by a
human at low intervals during the intervention and delivered
through electronic means, such as email, phone, and online chat.
Unguided will be defined as an intervention that that does not
provide support related to the therapeutic content but may
involve support related to the intervention itself (eg, instruction
on how to use the program) and/or automated feedback.
“Blended” interventions or those involving any face-to-face
support during the intervention will be excluded from either
definition.
Comorbidities will be defined as target populations with a
comorbid somatic disorder. Control group will be
operationalized according to the Comparators section and study
quality according to the Risk of Bias section.
Study Identification and Selection
Relevant articles will be identified according to the following
steps. First, a database search will be conducted using a sensitive
search strategy for the Cochrane Central Register of Controlled
Trials (CENTRAL), PsycINFO, EMBASE, and MEDLINE.
The sensitivity of the strategy will be validated a priori using a
sample set of articles from previous meta-analyses. In a second
step, studies included in reference lists of relevant existing
systematic reviews and meta-analyses will be checked for
eligibility. In a third step, a hand search will be conducted of
the reference lists of all included studies.
In the case of missing data, we will contact trialists for
information on unpublished or ongoing studies, or to request
additional trial data and determine eligibility for inclusion in
this review. The search will be restricted to studies published
in the 30 years from January 1990 to April 2019.
The selection of articles will be conducted by two independent
reviewers (IM and IC). In the first step, they will screen all titles
and abstracts yielded by the database search. In the second step,
full texts of the selected articles will be retrieved and screened
in terms of the aforementioned eligibility criteria. Disagreement
will be resolved by a discussion among the reviewers. When
needed to resolve a disagreement, a third reviewer (LS) will be
consulted. We will identify and exclude duplicate records, and
we will collate multiple reports that relate to the same study so
that each study rather than each report is the unit of interest in
the review. We will record all decisions made during the
selection process in sufficient detail with numbers of studies
and references to complete a PRISMA flow diagram and
“characteristics of included studies” and “characteristics of
excluded studies” tables at the end of the review (see Figure 1).
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Figure 1. PRISMA flow diagram.
Data Collection
We will use a data extraction spreadsheet to extract study
characteristics and outcome data. Two review authors (IM and
IC) will extract study characteristics and outcome data from the
included studies. Individuals involved in the data extraction
process will not be blinded regarding study authors, journal, or
institution. We will extract the following study characteristics:
1. Study identification items: description of trial, including
primary researcher and year of publication;
2. Study design: sample size, methodology, target mental
disorders, control group, and duration of intervention;
3. Study setting: nationality, environment (community,
primary care, secondary care), and specific population
groups (eg, worker population, students, diabetes patients);
4. Participants: N, mean age, gender, primary diagnosis,
comorbid diagnoses, and severity of condition;
5. Interventions: therapeutic theoretical approach (eg, CBT),
guidance (guided or unguided); and
6. Outcome measures: primary and secondary outcomes as
listed in Main Outcomes and Additional Outcomes herein.
Risk of Bias (Quality) Assessment
To evaluate the quality of the research, two independent
reviewers will assess the risk of bias for each study using the
criteria outlined in the risk of bias tool for randomized trials
[61,62]. Any disagreement will be resolved by a discussion
among the reviewers. When needed to resolve a disagreement,
a third researcher (LS) will be consulted.
Risk of bias will be assessed in the following domains: (1)
selection bias, (2) performance bias, (3) detection bias, (4)
attrition bias, (5) reporting bias, and (6) other bias. Risk of bias
in each domain will be judged as “low,” “unclear,” or “high.”
We will summarize the risk of bias judgments across different
studies for each of the domains listed. Overall risk of bias will
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be derived based on the risk of bias tool for randomized trials;
a score of low=1, unclear=2, and high=3 will be given for each
domain. The sum of all domain scores will be used as the overall
risk of bias indicator.
Study heterogeneity will be calculated with the I2 statistic. A
random-effects model will be assumed. A value of 0% indicates
no heterogeneity; higher values indicate higher heterogeneity.
A heterogeneity of 25% is defined as the threshold for low, 50%
for moderate, and 75% for high [63]. To account for uncertainty,
95% confidence intervals will be calculated for I2. In addition,
predictive intervals will be reported to estimate the range of the
true effect [64].
We will use a funnel plot and Q-Q plot to detect potential
biasing effects. Asymmetry will be tested using the Egger test
[65].
Strategy for Data Analysis and Synthesis
Interrater Reliability
Cohen kappa will be calculated to assess interrater reliability
for categorical variables and intraclass correlation for continuous
variables [66,67]. Disagreements will be solved by discussion.
Effect Sizes
Cohen d will be used for between-group effect size [68]:
Differences in groups’ means will be divided by their pooled
standard deviation. If d is not reported, available coefficients
(eg, r) will be transformed or d will be calculated based on given
information (eg, t value, N, F value, beta). If insufficient
information is provided for the calculation, the corresponding
author will be contacted [69].
Quantitative Data Synthesis and Statistical Calculations
The meta-analytic effect size will be estimated using a
three-level meta-regression model with random effects [70,71].
By assuming a three-level structure, we account for three
different variance components distributed over the three levels
in the model. This includes sampling variance of the extracted
effect sizes at level one, variance between the extracted effect
sizes from the same study at level two, and variance between
studies at level three [56]. The three-level model will be
compared with a two-level model by information criteria to
evaluate the need for a three-level structure.
To investigate the development in effect size over time, the
primary moderator of interest will be time. Both linear and
quadratic time trends will be assumed. In addition, moderators,
as outlined previously, will be inserted in the model. Two
regression models will be used: (1) a parsimonious model, in
which only single meta-regression significant predictors are
included (“parsimonious model”) and (2) a model including all
predictors. Models will be compared using information criteria.
All analyses will be conducted using R [72]. The package
“metafor” will be used as the primary analysis package [71,73].
Results
The search was completed after submitting the protocol in
mid-2019. Data analysis was completed at the end of 2019. We
expect the results to be submitted for publication in early 2020.
Discussion
This systematic review will address a significant lack of research
examining the field of IBIs for the treatment of depression from
a temporal perspective. Specifically, it will provide valuable
analysis of how the effectiveness of interventions has changed
over time and identify relevant moderators and study
characteristics that may be related to possible changes in
efficacy. This is especially important given the rapid rise in
internet-based interventions for the treatment of depression over
the past decade and the challenges that exist in treating the
enormous disease burden of depression.
To the best of our knowledge, this is the first planned study that
will review the field of IBIs from a temporal perspective. In so
doing, it will shed light on where research has been both over-
and underfocused over the past three decades, alert researchers
and funding bodies to important research questions that have
not been given sufficient attention, and expose methodological
shortcomings affecting research to date, thus providing valuable
guidance on next steps for the field.
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